Description
The abstract identifies PDE4B as the key target but doesn’t explain why this specific isoform is preferentially affected over PDE4A, PDE4C, or PDE4D. Understanding isoform selectivity is crucial for developing targeted therapeutics with fewer side effects.
Gap type: unexplained_observation Source paper: Shenghui decoction inhibits neuronal cell apoptosis to improve Alzheimer’s disease through the PDE4B/cAMP/CREB signaling pathway. (None, None, PMID:39787692)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:33.140639+00:00”, “resolution_summary”: “Resolved by hypothesis h-67914e81: PDE4 Inhibition as Inflammatory Reset for PD Oligodendrocytes. Supporting evidence includes debate sess_SDA-2026-04-14-gap-pubmed-20260410-193244-89904941_20260416-035819.”, “match_counts”: {“hypothesis_matches”: 1, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-67914e81”, “title”: “PDE4 Inhibition as Inflammatory Reset for PD Oligodendrocytes”, “score”: 0.435, “reason”: “13 token overlaps; entity overlap: pde4, pde4a, pde4b, pde4d”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-150500-e110aab9”, “target_gene”: “PDE4A, PDE4B, PDE4D”, “target_pathway”: “cAMP signaling / PDE inhibition”, “disease”: “neuroinflammation”, “composite_score”: 0.748744, “confidence_score”: 0.68, “status”: “promoted”, “pubmed_evidence_ids”: [“24293318”, “27733608”, “30260505”, “35517783”, “36584795”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-193244-89904941_20260416-035819”, “title”: “The abstract identifies APOE4’s primary effect on oligodendrocyte cholesterol metabolism but doesn’t explain the mechanistic pathway. Understanding this mechanism is critical for developing targeted therapeutics that address the root cause rather than downstream effects.\n\nGap type: unexplained_observation\nSource paper: APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes (2022, Nature, PMID:34788101)”, “score”: 0.502, “reason”: “14 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-193244-89904941”, “quality_score”: 0.69, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-15-gap-pubmed-20260411-090658-7651c1d2_20260416-033018”, “title”: “The abstract shows p53 is a central regulator of C9orf72-mediated neurodegeneration but doesn’t explain how poly(PR) specifically activates p53. Understanding this upstream trigger mechanism is critical for developing targeted therapeutic interventions.\n\nGap type: unexplained_observation\nSource paper: p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR). (None, None, PMID:33482083)”, “score”: 0.499, “reason”: “13 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-15-gap-pubmed-20260411-090658-7651c1d2”, “quality_score”: 0.61, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c_task_9aae8fc5”, “title”: “The abstract identifies that neurons show resistance to autophagy induction, but the mechanistic basis remains incompletely defined. Understanding this resistance is crucial for developing neuron-targeted autophagy therapies for ALS.\n\nGap type: unexplained_observation\nSource paper: Autophagy and ALS: mechanistic insights and therapeutic implications. (2022, Autophagy, PMID:34057020)”, “score”: 0.441, “reason”: “11 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c”, “quality_score”: 0.65, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-08-gap-pubmed-20260406-062222-b5f44522”, “title”: “The abstract identifies tissue-specific networks that may underlie Mendelian disease phenotypes but doesn’t explain the mechanistic basis for why the same genetic variant causes different phenotypes across tissues. Understanding these mechanisms is crucial for developing tissue-targeted therapies for neurogenetic disorders.\n\nGap type: unexplained_observation\nSource paper: A reference map of the human binary protein interactome. (2020, Nature, PMID:32296183)”, “score”: 0.438, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-08-gap-pubmed-20260406-062222-b5f44522”, “quality_score”: 0.95, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-08-gap-pubmed-20260406-062132-5d93ddb2_task_9aae8fc5”, “title”: “The review covers various organelle-specific autophagy types but doesn’t address what molecular mechanisms determine which organelles are selectively targeted for autophagy in neurodegeneration. This selectivity mechanism is crucial for understanding disease progression and therapeutic intervention.\n\nGap type: open_question\nSource paper: Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles. (2021, Autophagy, PMID:32048886)”, “score”: 0.435, “reason”: “11 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-08-gap-pubmed-20260406-062132-5d93ddb2”, “quality_score”: 0.655, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}